Tortugas Neuroscience
PrivateLast Round
Series A
Aug 3, 2026
Total Funding Raised
$151M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Tortugas Neuroscience is a biotechnology company that develops novel medicines for neurological and neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tortugas Neuroscience Comparables
Compare Tortugas Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Leal Therapeutics | 85% | |
| MapLight Therapeutics | 78% | |
| Minerva Neurosciences | 77% |
Tortugas Neuroscience Funding Rounds
Historical fundraising activity
Tortugas Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series A |
| AN Venture Partners | Series A |
| Cure Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
$76M round led by AN Venture Partners and The Column Group.
- Apr 21, 2026
$106M round closed
Recent news
Latest coverage and updates
- partners_withOct 13, 2026
Tortugas Neuroscience, Inc. and Hansoh Pharmaceutical Group partner on a Phase IIb clinical trial of obuprazine for acute schizophrenia in China and report that it achieves its primary endpoint on Oct 13th '26.
- hiresSep 9, 2026
Tortugas Neuroscience, Inc. announces the appointment of veteran biotech CFO Jim Frates to its Board of Directors and as Audit Committee chair on Sep 9th '26 in Massachusetts to support advancement of its CNS clinical pipeline.
Tortugas Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tortugas Neuroscience's valuation, stock price, and market status.
Is Tortugas Neuroscience a public or private company?
Tortugas Neuroscience is a private company.
What is the current stock price of Tortugas Neuroscience?
Tortugas Neuroscience is a private company, so its shares have no public market price. Caplight tracks Tortugas Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tortugas Neuroscience worth (valuation)?
Valuation information for Tortugas Neuroscience is not publicly available.
Can I buy Tortugas Neuroscience stock?
Tortugas Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tortugas Neuroscience's last funding round?
Tortugas Neuroscience's most recent funding round was Series A on August 3, 2026.
Who are the main investors in Tortugas Neuroscience?
Key investors in Tortugas Neuroscience include The Column Group, AN Venture Partners, Cure Ventures.
Will Tortugas Neuroscience IPO soon?
No public IPO plans have been announced for Tortugas Neuroscience.
How can I track Tortugas Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Tortugas Neuroscience's shares on secondary markets.